DNA content in the diagnostic biopsy for benign-adjacent and cancer-tissue areas predicts the need for treatment in men with T1c prostate cancer undergoing surveillance in an expectant management programme
Isharwal, S., D.V. Makarov, H.B. Carter,J.I. Epstein, A.W. Partin, P. Landis, C. Marlow, and R.W. Veltri
Prediction of patient-specific risk and percentile cohort risk of pathological stage outcome using continuous prostate-specific antigen measurement, clinical stage and biopsy Gleason score
Huang, Y., S. Isharwal, A. Haese, F.K.H. Chun,D.V. Makarov, Z. Feng, M. Han, E. Humphreys, J.I. Epstein, A.W. Partin, and R.W. Veltri
Patterns of Care and Outcomes Associated With Intensity-Modulated Radiation Therapy Versus Conventional Radiation Therapy for Older Patients With Head-and-Neck Cancer